1. Home
  2. GNPX vs AREB Comparison

GNPX vs AREB Comparison

Compare GNPX & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • AREB
  • Stock Information
  • Founded
  • GNPX 2009
  • AREB 2014
  • Country
  • GNPX United States
  • AREB United States
  • Employees
  • GNPX N/A
  • AREB N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • GNPX Health Care
  • AREB Industrials
  • Exchange
  • GNPX Nasdaq
  • AREB Nasdaq
  • Market Cap
  • GNPX 5.5M
  • AREB 8.4M
  • IPO Year
  • GNPX 2018
  • AREB N/A
  • Fundamental
  • Price
  • GNPX $0.23
  • AREB $0.69
  • Analyst Decision
  • GNPX
  • AREB
  • Analyst Count
  • GNPX 0
  • AREB 0
  • Target Price
  • GNPX N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • GNPX 13.6M
  • AREB 382.3K
  • Earning Date
  • GNPX 08-14-2025
  • AREB 08-12-2025
  • Dividend Yield
  • GNPX N/A
  • AREB N/A
  • EPS Growth
  • GNPX N/A
  • AREB N/A
  • EPS
  • GNPX N/A
  • AREB N/A
  • Revenue
  • GNPX N/A
  • AREB $9,474,958.00
  • Revenue This Year
  • GNPX N/A
  • AREB N/A
  • Revenue Next Year
  • GNPX N/A
  • AREB N/A
  • P/E Ratio
  • GNPX N/A
  • AREB N/A
  • Revenue Growth
  • GNPX N/A
  • AREB N/A
  • 52 Week Low
  • GNPX $0.14
  • AREB $0.68
  • 52 Week High
  • GNPX $3.97
  • AREB $193.48
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 58.63
  • AREB 21.23
  • Support Level
  • GNPX $0.14
  • AREB $0.70
  • Resistance Level
  • GNPX $0.17
  • AREB $0.89
  • Average True Range (ATR)
  • GNPX 0.03
  • AREB 0.11
  • MACD
  • GNPX 0.01
  • AREB -0.04
  • Stochastic Oscillator
  • GNPX 77.49
  • AREB 1.25

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: